Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 21, 2013Cancer DiscoveryOpen Access

Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

TPTea PemovskaMedical University of ViennaMKMika KontroUniversity of HelsinkiBYBhagwan YadavUniversity of Helsinki

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pemovska et al. (2013) studied this question.

synapsesocial.com/papers/6a12bbf85bb7edc7189e335dhttps://doi.org/10.1158/2159-8290.cd-13-0350
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing2003 · 30 citations
  2. 2mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs2010 · 768 citations
  3. 3Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening2012 · 154 citations